Welcome to the new Symbiosis state-of-the-art facility, expanding our capabilities in aseptic manufacturing.
At Symbiosis, we are committed to meeting the evolving needs of biopharmaceutical manufacturing to deliver innovation and quality in our services. We are thrilled to announce a significant milestone in this journey with the opening of our cutting-edge, 20,000 sq ft facility dedicated to sterile manufacturing processes.
That’s equivalent to:
The new Bruce Building facility is designed with our client’s needs at it’s core. We’ve built our laboratories to meet the most stringent industry standards, instilling confidence in our clients.
This investment in quality allows us to offer you:
We have enhanced our manufacturing process with:
Our new facility significantly increases our existing manufacturing capabilities:
Entrust us to manufacture your products in line with the most up-to-date global standards. Our new facility is aligned with the latest regulatory guidelines:
To support our new facility, we have expanded our current team of highly trained professionals by approximately 25%, ensuring we have the expertise to fully leverage our new capabilities and provide you with a continuously high-quality service.
Discover how our expanded capabilities can accelerate your drug development journey.
Contact us below for more information or to schedule a meeting.
Scion House, Stirling Innovation Park, Stirling, FK9 4NF, Scotland, UK.
2nd Floor, 625 Massachusetts Ave, Cambridge, MA 02139, USA
Want to be the first to know about our latest capabilities and offerings? Subscribe for Exclusive Updates